T1	Participants 111 136	granulocytopenic patients
T2	Participants 413 438	granulocytopenic patients
T3	Participants 440 448	Patients
T4	Participants 503 550	group 1 (carcinoma, lymphoma, multiple myeloma)
T5	Participants 578 631	group 2 (acute leukemia, bone marrow transplantation)
